FDA Inspection 1277660 — Aspirus Wausau Hospital IRB
The FDA completed an inspection of Aspirus Wausau Hospital IRB on Aug 1, 2025 in Wausau, WI. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 1, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Wausau, WI (United States)
Additional Details
IRB